Commodore Capital LP 13D and 13G filings for Ambrx Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-27 4:05 pm Sale | 2023-04-24 | 13G | Ambrx Biopharma Inc. AMAM | Commodore Capital LP | 31,181,983 8.100% | -4,518,017 (-12.66%) | Filing |
| 2023-03-03 4:10 pm Purchase | 2023-02-23 | 13G | Ambrx Biopharma Inc. AMAM | Commodore Capital LP | 35,700,000 13.200% | 9,450,000 (+36.00%) | Filing |
| 2023-03-03 4:05 pm Purchase | 2023-02-21 | 13G | Ambrx Biopharma Inc. AMAM | Commodore Capital LP | 26,250,000 9.700% | 26,250,000 (New Position) | Filing |